<img alt="" src="https://secure.inventiveperception365.com/789096.png" style="display:none;">
Support
Investors
Contact
Careers
Company
Leadership
News
Investors
Our Commitment
Patents
Subscribe
Contact
Careers

TAKE THE NEXT STEP

Learn more by getting in touch with Rapid Micro Biosystems today

CONTACT US
Solutions
The Growth Direct System
Process Automation Rapid Detection Consumables Technology Data & Reporting
Software
RMBNucleus™ RMBNucleus™ Mold Alarm
Services
Validation Services Support Services Request a Demo Certificates of Analysis & Safety Data Sheets
Applications
Environmental Monitoring
Water Testing
Bioburden Testing
Sterility Testing
Learning Center
Rapid Blog
Publications
Industry Events
Webinars
Rapid Resources

GROWTH DIRECT BROCHURE

Learn about the important advantages Growth Direct offers your facility

Download

    News

    News listing page

    Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

    Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025

    Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance

    Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany

    Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

    Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue

    Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference

    Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

    Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

    Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024

    Rapid Micro Biosystems CEO Interview with Newsweek - Investment Reports

    Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

    Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024

    Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024

    Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

    Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2024

    Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

    Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

    Rapid Micro Biosystems to Announce Fourth Quarter & Full Year 2023 Financial Results on March 1, 2024

    Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System

    Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue

    Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing

    Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference

    Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

    Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results

    Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 - 4

    Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase

    Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference

    Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results

    Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023

    Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

    Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

    Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing

    Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023

    Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance

    Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference

    Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

    Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue

    Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference

    Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology

    Rapid Micro Biosystems® Concludes Review of Strategic Alternatives

    Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022

    Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System

    Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference

    Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference

    Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value

    Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results

    Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management

    Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference

    Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022

    Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook

    Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results

    Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference

    Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021

    Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer

    Rapid Micro Biosystems Set to Join Russell 2000®, Russell 3000® and Russell Microcap® Indexes

    Rapid Micro Biosystems to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

    Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook

    Rapid Micro Biosystems to Announce Second Quarter 2021 Financial Results on August 26, 2021

    Rapid Micro Biosystems Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering

    Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

    Rapid Micro Biosystems Announces Pricing of Initial Public Offering

    Rapid Micro Biosystems Appoints Sean Maynard as Asia Pacific Commercial General Manager

    Rapid Micro Biosystems Announces the addition of Kristine Williams and Jonathan Paris to the Executive Leadership Team to Support Continued Growth

    Rapid Micro Biosystems Raises $81M to Continue Global Expansion of Automated Pharmaceutical QC Platform

    Rapid Micro Biosystems Hires Senior Vice President of Strategy

    Rapid Micro Biosystems Hires Chief Operating Officer

    Rapid Micro Biosystems Hires Chief Human Resources Officer

    Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing

    Nephron, Rapid Micro Announce First-of-its-Kind Automated Microbial Monitoring

    Rapid Micro Biosystems Announces New Vice President of Global Sales

    Rapid Micro Biosystems Announces New Chief Financial Officer

    Rapid Micro Biosystems Secures $60 Million In Equity Financing

    Rapid Micro Biosystems announces New Vice President of Operations

    Rapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for Vaccines

    CONTACT US
    Request a Demo